CAR-T–cell neurotoxicity: Hope is on the Horizon

Abstract

In this issue of Blood, Karschnia et al spotlight the “Achilles heel” of chimeric antigen receptor (CAR) T-cell therapy and call for prospective clinical trials to evaluate strategies to manage and potentially prevent CAR T cell–induced neurotoxicity (NT).1